Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
DOCS · against 223 other Healthcare companies of similar size
Ranked #111 of 224 · scores higher than 51% of peers
Bars: peers in each 10-point band of the valuation score30 peers with a valuation score of 50–59, including DOCS · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | DOCS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 221 reported | 2.6% | 2.5% | 53% | 30% | |
| EBITDA yieldHigher is better · 222 reported | 4.1% | 4.6% | 47% | 50% | |
| Free cash flow yieldHigher is better · 124 reported | 5.1% | 1.2% | 80% | 20% | |
| Book yieldHigher is better · 223 reported | 15.6% | 24.5% | 34% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 3 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 5 | 22.0B CNY (≈$3.1B) | 96 | 67 | |
| 106 | 414.8B INR (≈$5.0B) | 55 | 73 | |
| 106 | 494.7B INR (≈$5.9B) | 55 | 70 | |
| 106 | 3.0B USD | 55 | 39 | |
| 106 | 9.3B USD | 55 | 64 | |
| 111 | 5.8B USD | 54 | 68 | |
| 112 | 21.5B DKK (≈$3.2B) | 53 | 58 | |
| 112 | 5.5B USD | 53 | 43 | |
| 114 | 49.0B CNY (≈$6.9B) | 52 | 60 | |
| 114 | 10.0B USD | 52 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score